Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 79 | 2024 | 2139 | 11.460 |
Why?
|
Coronary Artery Disease | 98 | 2024 | 6569 | 8.250 |
Why?
|
Angioplasty, Balloon, Coronary | 56 | 2021 | 1724 | 5.790 |
Why?
|
Myocardial Revascularization | 42 | 2024 | 796 | 5.740 |
Why?
|
Myocardial Infarction | 132 | 2024 | 11521 | 4.730 |
Why?
|
Coronary Artery Bypass | 47 | 2023 | 2194 | 4.640 |
Why?
|
Angina Pectoris | 42 | 2023 | 957 | 4.640 |
Why?
|
Cardiovascular Agents | 35 | 2024 | 849 | 4.370 |
Why?
|
Niacin | 14 | 2024 | 117 | 4.330 |
Why?
|
Hypolipidemic Agents | 16 | 2019 | 609 | 3.110 |
Why?
|
Cholesterol, HDL | 20 | 2023 | 1820 | 3.100 |
Why?
|
Angina, Unstable | 33 | 2022 | 893 | 3.040 |
Why?
|
Acute Coronary Syndrome | 30 | 2024 | 2194 | 2.700 |
Why?
|
Coronary Disease | 50 | 2023 | 5919 | 2.560 |
Why?
|
Hypertriglyceridemia | 6 | 2024 | 293 | 2.510 |
Why?
|
Platelet Aggregation Inhibitors | 35 | 2021 | 2763 | 2.350 |
Why?
|
Coronary Angiography | 51 | 2024 | 4541 | 2.030 |
Why?
|
Cardiovascular Diseases | 37 | 2024 | 15661 | 1.940 |
Why?
|
Electrocardiography | 72 | 2018 | 6413 | 1.930 |
Why?
|
Dyslipidemias | 7 | 2022 | 873 | 1.850 |
Why?
|
Calcium Channel Blockers | 16 | 2020 | 691 | 1.630 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 20 | 2024 | 3253 | 1.510 |
Why?
|
Vasodilator Agents | 12 | 2017 | 990 | 1.490 |
Why?
|
Ischemia | 16 | 2023 | 1900 | 1.490 |
Why?
|
Diltiazem | 21 | 2001 | 132 | 1.490 |
Why?
|
Eicosapentaenoic Acid | 8 | 2024 | 565 | 1.470 |
Why?
|
Myocardial Perfusion Imaging | 10 | 2024 | 672 | 1.330 |
Why?
|
Exercise Test | 27 | 2024 | 2187 | 1.300 |
Why?
|
Nitrates | 8 | 2017 | 260 | 1.280 |
Why?
|
Practice Guidelines as Topic | 27 | 2024 | 7460 | 1.270 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 9 | 2019 | 1141 | 1.270 |
Why?
|
Adrenergic beta-Antagonists | 23 | 2020 | 1243 | 1.270 |
Why?
|
Randomized Controlled Trials as Topic | 44 | 2024 | 10400 | 1.220 |
Why?
|
Coronary Vessels | 12 | 2022 | 3124 | 1.210 |
Why?
|
Drug-Eluting Stents | 7 | 2016 | 681 | 1.180 |
Why?
|
Ticlopidine | 15 | 2016 | 730 | 1.180 |
Why?
|
Humans | 404 | 2024 | 768970 | 1.150 |
Why?
|
Terminology as Topic | 2 | 2024 | 1541 | 1.120 |
Why?
|
Triglycerides | 14 | 2024 | 2464 | 1.100 |
Why?
|
Treatment Outcome | 107 | 2024 | 65480 | 1.080 |
Why?
|
Coronary Stenosis | 10 | 2018 | 802 | 1.070 |
Why?
|
Atherosclerosis | 14 | 2024 | 3431 | 1.040 |
Why?
|
Thrombolytic Therapy | 13 | 2018 | 2055 | 0.960 |
Why?
|
Hyperlipidemias | 4 | 2024 | 773 | 0.940 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 11 | 2011 | 577 | 0.900 |
Why?
|
Nitroglycerin | 3 | 2015 | 332 | 0.840 |
Why?
|
Risk Assessment | 44 | 2024 | 24333 | 0.840 |
Why?
|
Drug Therapy, Combination | 33 | 2018 | 6320 | 0.830 |
Why?
|
Aspirin | 16 | 2018 | 3135 | 0.830 |
Why?
|
Fibrinolytic Agents | 9 | 2014 | 2080 | 0.800 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2022 | 346 | 0.800 |
Why?
|
Vasodilation | 2 | 2017 | 967 | 0.780 |
Why?
|
Secondary Prevention | 10 | 2018 | 1476 | 0.770 |
Why?
|
Clinical Trials as Topic | 23 | 2024 | 8055 | 0.760 |
Why?
|
Coronary Circulation | 5 | 2021 | 1617 | 0.750 |
Why?
|
Risk Factors | 84 | 2024 | 74976 | 0.730 |
Why?
|
Diabetes Mellitus | 9 | 2023 | 5892 | 0.720 |
Why?
|
Cholesterol, LDL | 14 | 2023 | 2403 | 0.720 |
Why?
|
Renal Insufficiency, Chronic | 10 | 2022 | 2297 | 0.680 |
Why?
|
Coronary Occlusion | 1 | 2023 | 306 | 0.670 |
Why?
|
Time Factors | 56 | 2024 | 40261 | 0.660 |
Why?
|
Stents | 12 | 2021 | 3200 | 0.660 |
Why?
|
Exercise Tolerance | 6 | 2024 | 846 | 0.660 |
Why?
|
Translating | 1 | 2020 | 144 | 0.660 |
Why?
|
Disease Management | 6 | 2022 | 2537 | 0.650 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2019 | 127 | 0.630 |
Why?
|
Vascular Diseases | 3 | 2023 | 1163 | 0.600 |
Why?
|
Delivery of Health Care | 6 | 2021 | 5375 | 0.600 |
Why?
|
Unnecessary Procedures | 1 | 2021 | 419 | 0.590 |
Why?
|
Middle Aged | 160 | 2024 | 223737 | 0.590 |
Why?
|
Syndrome | 14 | 2021 | 3274 | 0.590 |
Why?
|
Aged | 132 | 2024 | 171786 | 0.580 |
Why?
|
Lipoproteins | 3 | 2018 | 880 | 0.570 |
Why?
|
Risk Reduction Behavior | 6 | 2022 | 1119 | 0.570 |
Why?
|
Myocardial Reperfusion | 3 | 2008 | 339 | 0.570 |
Why?
|
Male | 185 | 2024 | 365203 | 0.560 |
Why?
|
Anticholesteremic Agents | 8 | 2018 | 972 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 14 | 2023 | 12253 | 0.550 |
Why?
|
Female | 196 | 2024 | 397515 | 0.540 |
Why?
|
Delayed-Action Preparations | 8 | 2019 | 969 | 0.530 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 677 | 0.510 |
Why?
|
Quality of Life | 28 | 2024 | 13510 | 0.490 |
Why?
|
Tyrosine | 4 | 2008 | 1427 | 0.490 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1550 | 0.480 |
Why?
|
Prognosis | 39 | 2024 | 30046 | 0.470 |
Why?
|
Thrombosis | 6 | 2018 | 2956 | 0.470 |
Why?
|
Health Care Reform | 2 | 2017 | 1262 | 0.470 |
Why?
|
Insulin | 3 | 2016 | 6610 | 0.460 |
Why?
|
Diabetic Angiopathies | 4 | 2015 | 806 | 0.460 |
Why?
|
Diagnostic Techniques, Cardiovascular | 2 | 2016 | 153 | 0.450 |
Why?
|
Testosterone | 3 | 2023 | 2493 | 0.440 |
Why?
|
Chelation Therapy | 1 | 2013 | 77 | 0.440 |
Why?
|
Severity of Illness Index | 24 | 2024 | 15951 | 0.440 |
Why?
|
Predictive Value of Tests | 19 | 2024 | 15471 | 0.440 |
Why?
|
Health Expenditures | 2 | 2019 | 2396 | 0.430 |
Why?
|
Kaplan-Meier Estimate | 18 | 2020 | 6547 | 0.420 |
Why?
|
Coronary Restenosis | 3 | 2012 | 396 | 0.420 |
Why?
|
Heart Rate | 15 | 2018 | 4217 | 0.420 |
Why?
|
Cardiomyopathies | 2 | 2023 | 2057 | 0.420 |
Why?
|
Follow-Up Studies | 42 | 2024 | 39394 | 0.420 |
Why?
|
Acetanilides | 3 | 2011 | 169 | 0.410 |
Why?
|
Peripheral Arterial Disease | 4 | 2019 | 1304 | 0.410 |
Why?
|
Heart Diseases | 4 | 2012 | 2819 | 0.410 |
Why?
|
Androgens | 1 | 2020 | 1285 | 0.410 |
Why?
|
Combined Modality Therapy | 14 | 2018 | 8559 | 0.400 |
Why?
|
Cardiology | 6 | 2023 | 1701 | 0.400 |
Why?
|
Health Status | 12 | 2024 | 4095 | 0.400 |
Why?
|
Survival Rate | 17 | 2023 | 12873 | 0.400 |
Why?
|
Chelating Agents | 1 | 2013 | 385 | 0.400 |
Why?
|
Glucose Intolerance | 1 | 2016 | 579 | 0.390 |
Why?
|
Hypoglycemic Agents | 5 | 2019 | 3110 | 0.380 |
Why?
|
Multicenter Studies as Topic | 10 | 2010 | 1737 | 0.380 |
Why?
|
Cause of Death | 7 | 2023 | 3721 | 0.370 |
Why?
|
Double-Blind Method | 25 | 2023 | 12467 | 0.370 |
Why?
|
Coronary Care Units | 4 | 2008 | 235 | 0.370 |
Why?
|
Piperazines | 6 | 2013 | 2553 | 0.370 |
Why?
|
Verapamil | 3 | 2001 | 242 | 0.360 |
Why?
|
Echocardiography, Stress | 5 | 2024 | 139 | 0.350 |
Why?
|
Goals | 2 | 2024 | 717 | 0.350 |
Why?
|
Endpoint Determination | 5 | 2011 | 594 | 0.350 |
Why?
|
Lipoproteins, HDL | 5 | 2018 | 682 | 0.340 |
Why?
|
Simvastatin | 6 | 2019 | 346 | 0.340 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 8 | 2019 | 1514 | 0.340 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1904 | 0.330 |
Why?
|
Stroke | 22 | 2024 | 9756 | 0.330 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2023 | 2145 | 0.320 |
Why?
|
Coronary Thrombosis | 4 | 2011 | 440 | 0.320 |
Why?
|
Gemfibrozil | 4 | 2003 | 30 | 0.310 |
Why?
|
Creatine Kinase | 15 | 2024 | 684 | 0.310 |
Why?
|
Perioperative Care | 2 | 2017 | 1045 | 0.310 |
Why?
|
Evidence-Based Medicine | 8 | 2024 | 3709 | 0.300 |
Why?
|
Anticoagulants | 6 | 2009 | 4850 | 0.300 |
Why?
|
Tachycardia, Supraventricular | 1 | 2011 | 273 | 0.300 |
Why?
|
Drugs, Investigational | 1 | 2010 | 212 | 0.300 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3269 | 0.300 |
Why?
|
Cost-Benefit Analysis | 11 | 2023 | 5544 | 0.290 |
Why?
|
United States | 37 | 2023 | 73186 | 0.290 |
Why?
|
Hospitals, Veterans | 4 | 2002 | 395 | 0.290 |
Why?
|
Patient Admission | 3 | 2013 | 1370 | 0.280 |
Why?
|
Laboratories | 1 | 2011 | 463 | 0.280 |
Why?
|
Exercise Therapy | 1 | 2014 | 939 | 0.280 |
Why?
|
Fibrinolysis | 2 | 2007 | 331 | 0.270 |
Why?
|
Survival Analysis | 18 | 2020 | 10115 | 0.270 |
Why?
|
Hyperglycemia | 2 | 2013 | 1389 | 0.270 |
Why?
|
Enzyme Inhibitors | 5 | 2014 | 3726 | 0.270 |
Why?
|
Hypogonadism | 2 | 2023 | 805 | 0.260 |
Why?
|
Heart Conduction System | 2 | 2001 | 1009 | 0.260 |
Why?
|
Decision Trees | 4 | 2020 | 509 | 0.260 |
Why?
|
Guideline Adherence | 7 | 2019 | 2241 | 0.260 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2024 | 362 | 0.250 |
Why?
|
Stroke Volume | 7 | 2016 | 5622 | 0.250 |
Why?
|
Digoxin | 3 | 2000 | 246 | 0.250 |
Why?
|
Postoperative Complications | 7 | 2017 | 15889 | 0.250 |
Why?
|
Pacemaker, Artificial | 3 | 2024 | 828 | 0.250 |
Why?
|
Television | 1 | 2008 | 410 | 0.250 |
Why?
|
Registries | 6 | 2021 | 8384 | 0.250 |
Why?
|
Hypertension | 10 | 2023 | 8617 | 0.240 |
Why?
|
Tachycardia, Ventricular | 2 | 2011 | 1309 | 0.240 |
Why?
|
Anti-Arrhythmia Agents | 4 | 2017 | 775 | 0.240 |
Why?
|
United States Department of Veterans Affairs | 7 | 2022 | 941 | 0.230 |
Why?
|
Thiophenes | 3 | 2013 | 570 | 0.230 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2021 | 1064 | 0.230 |
Why?
|
Mitral Valve Insufficiency | 2 | 2024 | 1415 | 0.230 |
Why?
|
Microcirculation | 1 | 2009 | 1281 | 0.230 |
Why?
|
Recurrence | 18 | 2018 | 8513 | 0.220 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1515 | 0.220 |
Why?
|
Government Regulation | 1 | 2008 | 525 | 0.220 |
Why?
|
Hemorrhage | 9 | 2024 | 3466 | 0.220 |
Why?
|
History, 21st Century | 4 | 2018 | 1575 | 0.210 |
Why?
|
Antihypertensive Agents | 3 | 2019 | 2027 | 0.210 |
Why?
|
Acute Disease | 13 | 2005 | 7245 | 0.210 |
Why?
|
Lipids | 2 | 2009 | 3345 | 0.210 |
Why?
|
Insurance, Health | 2 | 2019 | 2518 | 0.200 |
Why?
|
Incidence | 12 | 2021 | 21547 | 0.200 |
Why?
|
Cardiology Service, Hospital | 1 | 2004 | 242 | 0.200 |
Why?
|
Hospitals, Urban | 1 | 2004 | 499 | 0.200 |
Why?
|
Blood Glucose | 2 | 2016 | 6435 | 0.200 |
Why?
|
Aged, 80 and over | 22 | 2024 | 59739 | 0.200 |
Why?
|
Proportional Hazards Models | 15 | 2020 | 12562 | 0.190 |
Why?
|
Hippocratic Oath | 1 | 2021 | 16 | 0.190 |
Why?
|
Heart Failure | 9 | 2023 | 11879 | 0.190 |
Why?
|
Chronic Disease | 10 | 2024 | 9384 | 0.190 |
Why?
|
History, 20th Century | 4 | 2018 | 2771 | 0.190 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2228 | 0.190 |
Why?
|
Prospective Studies | 24 | 2021 | 54962 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2021 | 10765 | 0.180 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2024 | 560 | 0.180 |
Why?
|
Defibrillators, Implantable | 2 | 2024 | 1498 | 0.180 |
Why?
|
Comorbidity | 11 | 2019 | 10592 | 0.180 |
Why?
|
Drug Therapy | 2 | 2010 | 504 | 0.180 |
Why?
|
Ontario | 2 | 2024 | 403 | 0.180 |
Why?
|
Felodipine | 2 | 1997 | 3 | 0.170 |
Why?
|
Phenethylamines | 1 | 2000 | 95 | 0.170 |
Why?
|
Peptides | 4 | 2008 | 4353 | 0.170 |
Why?
|
Blood Platelets | 1 | 2010 | 2479 | 0.160 |
Why?
|
Referral and Consultation | 3 | 2022 | 3628 | 0.160 |
Why?
|
Risk | 8 | 2018 | 9621 | 0.160 |
Why?
|
Brugada Syndrome | 2 | 2011 | 98 | 0.160 |
Why?
|
Cardiomegaly | 3 | 1992 | 591 | 0.160 |
Why?
|
Preventive Medicine | 2 | 2017 | 246 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2008 | 446 | 0.150 |
Why?
|
Troponin | 4 | 2011 | 535 | 0.150 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 279 | 0.150 |
Why?
|
Isoenzymes | 11 | 2005 | 1687 | 0.150 |
Why?
|
Data Interpretation, Statistical | 2 | 2007 | 2714 | 0.150 |
Why?
|
Creatine Kinase, MB Form | 3 | 2020 | 202 | 0.150 |
Why?
|
Research Design | 8 | 2019 | 6214 | 0.150 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 13021 | 0.150 |
Why?
|
Exercise | 4 | 2018 | 5954 | 0.150 |
Why?
|
Sodium Channel Blockers | 1 | 2019 | 173 | 0.150 |
Why?
|
Hospitals | 1 | 2011 | 3904 | 0.150 |
Why?
|
Enalapril | 2 | 1997 | 317 | 0.150 |
Why?
|
Veterans | 5 | 2022 | 2672 | 0.150 |
Why?
|
Eating | 1 | 2024 | 1542 | 0.140 |
Why?
|
Hormone Replacement Therapy | 1 | 2023 | 757 | 0.140 |
Why?
|
Thoracic Surgery | 1 | 2024 | 729 | 0.140 |
Why?
|
Cohort Studies | 10 | 2023 | 41808 | 0.140 |
Why?
|
Coronary Sinus | 1 | 2017 | 85 | 0.140 |
Why?
|
Blood Pressure | 10 | 2019 | 8544 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2019 | 249 | 0.140 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1883 | 0.140 |
Why?
|
Brain Ischemia | 4 | 2018 | 3008 | 0.140 |
Why?
|
Internationality | 1 | 2022 | 1008 | 0.130 |
Why?
|
Life Style | 4 | 2019 | 3931 | 0.130 |
Why?
|
Cardiopulmonary Bypass | 1 | 2001 | 1097 | 0.130 |
Why?
|
Outpatients | 2 | 2021 | 1603 | 0.130 |
Why?
|
Age Factors | 9 | 2019 | 18435 | 0.130 |
Why?
|
Odds Ratio | 6 | 2016 | 9684 | 0.130 |
Why?
|
Administration, Sublingual | 1 | 2015 | 60 | 0.130 |
Why?
|
Hospital Mortality | 6 | 2013 | 5369 | 0.130 |
Why?
|
Canada | 6 | 2015 | 2130 | 0.130 |
Why?
|
Brachiocephalic Veins | 1 | 2015 | 21 | 0.130 |
Why?
|
Benzazepines | 3 | 1986 | 308 | 0.120 |
Why?
|
Meta-Analysis as Topic | 3 | 2001 | 1364 | 0.120 |
Why?
|
Disease Progression | 6 | 2011 | 13674 | 0.120 |
Why?
|
Tablets | 1 | 2015 | 149 | 0.120 |
Why?
|
Haptoglobins | 1 | 2016 | 165 | 0.120 |
Why?
|
Bioprosthesis | 2 | 1994 | 593 | 0.120 |
Why?
|
Chi-Square Distribution | 5 | 2013 | 3438 | 0.120 |
Why?
|
Clinical Protocols | 5 | 2019 | 1445 | 0.120 |
Why?
|
Azetidines | 2 | 2013 | 152 | 0.120 |
Why?
|
Health Care Costs | 2 | 2023 | 3270 | 0.120 |
Why?
|
Resource Allocation | 1 | 2017 | 354 | 0.120 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 417 | 0.120 |
Why?
|
Chemistry, Pharmaceutical | 2 | 2015 | 275 | 0.120 |
Why?
|
North America | 4 | 2013 | 1290 | 0.120 |
Why?
|
Adult | 43 | 2023 | 223851 | 0.120 |
Why?
|
Cardiac Care Facilities | 2 | 2011 | 35 | 0.120 |
Why?
|
Medicare | 1 | 2013 | 6888 | 0.110 |
Why?
|
Sex Factors | 6 | 2020 | 10633 | 0.110 |
Why?
|
Retrospective Studies | 24 | 2024 | 81903 | 0.110 |
Why?
|
Bayes Theorem | 4 | 2024 | 2360 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2021 | 841 | 0.110 |
Why?
|
Medical History Taking | 2 | 2015 | 779 | 0.110 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1999 | 856 | 0.110 |
Why?
|
Cholesterol | 2 | 2013 | 2913 | 0.110 |
Why?
|
Pyrazoles | 1 | 2024 | 2029 | 0.110 |
Why?
|
Medication Adherence | 3 | 2022 | 2192 | 0.110 |
Why?
|
Echocardiography | 4 | 2022 | 5047 | 0.110 |
Why?
|
Pericarditis | 2 | 1985 | 136 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 2 | 2018 | 1568 | 0.100 |
Why?
|
Aerosols | 1 | 2015 | 636 | 0.100 |
Why?
|
Angioplasty | 2 | 2015 | 357 | 0.100 |
Why?
|
Diabetes Complications | 3 | 2011 | 1320 | 0.100 |
Why?
|
Multivariate Analysis | 7 | 2016 | 12095 | 0.100 |
Why?
|
Apolipoprotein A-II | 1 | 1992 | 41 | 0.100 |
Why?
|
Connecticut | 2 | 2004 | 365 | 0.100 |
Why?
|
Early Diagnosis | 2 | 2015 | 1194 | 0.100 |
Why?
|
Societies, Scientific | 1 | 2013 | 223 | 0.100 |
Why?
|
Polysaccharides | 2 | 2009 | 1024 | 0.100 |
Why?
|
Patient Transfer | 3 | 2008 | 792 | 0.100 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1995 | 484 | 0.100 |
Why?
|
Streptokinase | 1 | 1991 | 186 | 0.090 |
Why?
|
Physician Executives | 1 | 2012 | 140 | 0.090 |
Why?
|
Myocardium | 4 | 2017 | 4790 | 0.090 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 285 | 0.090 |
Why?
|
Heart Valve Prosthesis | 2 | 1994 | 1468 | 0.090 |
Why?
|
Radionuclide Ventriculography | 3 | 2002 | 40 | 0.090 |
Why?
|
Communication Barriers | 1 | 2014 | 419 | 0.090 |
Why?
|
Hospitals, Community | 3 | 2008 | 365 | 0.090 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5176 | 0.090 |
Why?
|
Apolipoproteins B | 1 | 1992 | 386 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2630 | 0.090 |
Why?
|
Sulfonamides | 1 | 2000 | 1981 | 0.090 |
Why?
|
Enoxaparin | 2 | 2009 | 391 | 0.080 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12801 | 0.080 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 428 | 0.080 |
Why?
|
Hospital Units | 1 | 2011 | 142 | 0.080 |
Why?
|
Baltimore | 1 | 2010 | 233 | 0.080 |
Why?
|
Recovery of Function | 2 | 2018 | 2990 | 0.080 |
Why?
|
Prevalence | 6 | 2019 | 15879 | 0.080 |
Why?
|
Pyridines | 3 | 2018 | 2895 | 0.080 |
Why?
|
Renal Dialysis | 2 | 2018 | 1789 | 0.080 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2010 | 283 | 0.080 |
Why?
|
Physical Examination | 1 | 2015 | 1262 | 0.080 |
Why?
|
Decision Making | 2 | 2017 | 3953 | 0.080 |
Why?
|
Adenosine Diphosphate | 1 | 2010 | 422 | 0.080 |
Why?
|
Prostaglandins | 1 | 2010 | 398 | 0.080 |
Why?
|
Angiotensins | 1 | 2009 | 141 | 0.080 |
Why?
|
Labor, Obstetric | 6 | 1968 | 323 | 0.080 |
Why?
|
Nifedipine | 2 | 1988 | 220 | 0.080 |
Why?
|
Logistic Models | 5 | 2016 | 13318 | 0.080 |
Why?
|
Atrioventricular Block | 1 | 2010 | 141 | 0.080 |
Why?
|
Parasympathetic Nervous System | 1 | 1989 | 144 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 841 | 0.080 |
Why?
|
Health Behavior | 2 | 2018 | 2649 | 0.080 |
Why?
|
Xanthophylls | 1 | 2008 | 95 | 0.080 |
Why?
|
Health Literacy | 1 | 2014 | 467 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2018 | 2493 | 0.080 |
Why?
|
Tachycardia | 1 | 2011 | 599 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3683 | 0.080 |
Why?
|
Platelet Function Tests | 1 | 2010 | 275 | 0.080 |
Why?
|
Physical Fitness | 1 | 2013 | 744 | 0.080 |
Why?
|
Patient Selection | 3 | 2009 | 4265 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2010 | 430 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2018 | 2008 | 0.070 |
Why?
|
Linear Models | 3 | 2016 | 5891 | 0.070 |
Why?
|
Myocardial Contraction | 5 | 1984 | 1526 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 790 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20245 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 3 | 2023 | 1741 | 0.070 |
Why?
|
Animals | 12 | 2019 | 169335 | 0.070 |
Why?
|
American Heart Association | 2 | 2009 | 1051 | 0.070 |
Why?
|
Platelet Aggregation | 1 | 2010 | 769 | 0.070 |
Why?
|
Pulmonary Gas Exchange | 1 | 2009 | 389 | 0.070 |
Why?
|
Random Allocation | 8 | 1989 | 2394 | 0.070 |
Why?
|
Hypercholesterolemia | 2 | 2013 | 1145 | 0.070 |
Why?
|
Causality | 1 | 2013 | 1256 | 0.070 |
Why?
|
Heart Neoplasms | 3 | 1987 | 374 | 0.070 |
Why?
|
Radiography | 2 | 2016 | 6991 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1881 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2008 | 1947 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 1989 | 521 | 0.070 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1104 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4862 | 0.060 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4428 | 0.060 |
Why?
|
Kidney | 2 | 2022 | 7058 | 0.060 |
Why?
|
Heart Rupture | 1 | 1985 | 21 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5110 | 0.060 |
Why?
|
Statistics as Topic | 1 | 1992 | 2360 | 0.060 |
Why?
|
Uterus | 5 | 1968 | 663 | 0.060 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2004 | 184 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2007 | 344 | 0.060 |
Why?
|
Social Class | 1 | 2014 | 2009 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2019 | 4879 | 0.060 |
Why?
|
Length of Stay | 5 | 2021 | 6526 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2014 | 3941 | 0.060 |
Why?
|
Heart Ventricles | 4 | 2013 | 3840 | 0.060 |
Why?
|
Hospitalization | 7 | 2016 | 10847 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2437 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1101 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2007 | 489 | 0.060 |
Why?
|
Antifibrinolytic Agents | 1 | 2007 | 289 | 0.060 |
Why?
|
Physical Exertion | 1 | 1987 | 668 | 0.060 |
Why?
|
Blood Transfusion | 3 | 2008 | 1309 | 0.060 |
Why?
|
Bezafibrate | 1 | 2003 | 14 | 0.060 |
Why?
|
Ibuprofen | 1 | 1985 | 229 | 0.060 |
Why?
|
Japan | 1 | 2008 | 1418 | 0.050 |
Why?
|
Water-Electrolyte Balance | 1 | 2004 | 326 | 0.050 |
Why?
|
Consensus | 1 | 2013 | 3214 | 0.050 |
Why?
|
Coronary Aneurysm | 1 | 2006 | 234 | 0.050 |
Why?
|
Anniversaries and Special Events | 1 | 2004 | 97 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2009 | 2932 | 0.050 |
Why?
|
Antibodies, Monoclonal | 3 | 2008 | 9264 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
Lovastatin | 1 | 2003 | 115 | 0.050 |
Why?
|
Puerperal Disorders | 1 | 2006 | 304 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3813 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1658 | 0.050 |
Why?
|
Endocarditis | 2 | 1987 | 352 | 0.050 |
Why?
|
Diatrizoate | 1 | 1982 | 81 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2004 | 192 | 0.050 |
Why?
|
New York | 2 | 2019 | 884 | 0.050 |
Why?
|
Cryptococcosis | 1 | 1983 | 103 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2021 | 5323 | 0.050 |
Why?
|
Thallium Radioisotopes | 2 | 2002 | 139 | 0.050 |
Why?
|
Gels | 1 | 2023 | 423 | 0.050 |
Why?
|
Heart | 5 | 2023 | 4447 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2646 | 0.050 |
Why?
|
Angina Pectoris, Variant | 1 | 1981 | 53 | 0.050 |
Why?
|
History, 19th Century | 1 | 2004 | 715 | 0.050 |
Why?
|
Perfusion | 1 | 2006 | 1402 | 0.050 |
Why?
|
Benchmarking | 1 | 2008 | 1059 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1059 | 0.050 |
Why?
|
Leg | 2 | 2005 | 1089 | 0.050 |
Why?
|
Self Care | 1 | 2006 | 801 | 0.050 |
Why?
|
Quality of Health Care | 4 | 2009 | 4339 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1540 | 0.050 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2024 | 881 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18068 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2008 | 6856 | 0.050 |
Why?
|
Time | 1 | 2002 | 552 | 0.040 |
Why?
|
Fluid Therapy | 1 | 2004 | 587 | 0.040 |
Why?
|
Health Promotion | 1 | 2013 | 2210 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20776 | 0.040 |
Why?
|
Inpatients | 1 | 2012 | 2569 | 0.040 |
Why?
|
Radionuclide Imaging | 5 | 2011 | 1998 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22296 | 0.040 |
Why?
|
Acetates | 1 | 2001 | 317 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 452 | 0.040 |
Why?
|
Contrast Media | 2 | 2004 | 5334 | 0.040 |
Why?
|
Dystocia | 3 | 1968 | 36 | 0.040 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1672 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2010 | 5906 | 0.040 |
Why?
|
State Medicine | 1 | 2021 | 219 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2024 | 971 | 0.040 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 592 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3554 | 0.040 |
Why?
|
Patient Satisfaction | 4 | 2013 | 3492 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 298 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 168 | 0.040 |
Why?
|
Cardiac Complexes, Premature | 1 | 1978 | 63 | 0.040 |
Why?
|
Hemangioma | 1 | 1983 | 727 | 0.040 |
Why?
|
Critical Pathways | 1 | 2002 | 476 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2784 | 0.040 |
Why?
|
Smoking Cessation | 3 | 2018 | 2085 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 336 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2004 | 843 | 0.040 |
Why?
|
Cross-Over Studies | 3 | 2013 | 2108 | 0.040 |
Why?
|
Denmark | 1 | 2000 | 776 | 0.040 |
Why?
|
Systole | 1 | 1980 | 937 | 0.040 |
Why?
|
Program Development | 1 | 2004 | 1300 | 0.040 |
Why?
|
Thromboembolism | 1 | 2024 | 1004 | 0.040 |
Why?
|
New Zealand | 1 | 2018 | 360 | 0.040 |
Why?
|
Florida | 1 | 2019 | 430 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2000 | 409 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 3 | 2018 | 2258 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3139 | 0.030 |
Why?
|
Femoral Artery | 1 | 2001 | 829 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2004 | 973 | 0.030 |
Why?
|
Brucella Vaccine | 2 | 1967 | 3 | 0.030 |
Why?
|
Uterine Cervical Diseases | 2 | 1967 | 75 | 0.030 |
Why?
|
Brucella abortus | 2 | 1967 | 14 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2019 | 492 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 600 | 0.030 |
Why?
|
Algorithms | 5 | 2014 | 14201 | 0.030 |
Why?
|
Cardiac Output | 2 | 1981 | 838 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 353 | 0.030 |
Why?
|
Mass Screening | 1 | 2012 | 5457 | 0.030 |
Why?
|
Suture Techniques | 1 | 2001 | 779 | 0.030 |
Why?
|
Republic of Korea | 1 | 2018 | 592 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4040 | 0.030 |
Why?
|
Hypotension | 1 | 1982 | 888 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2006 | 2634 | 0.030 |
Why?
|
Smoking | 4 | 2018 | 9094 | 0.030 |
Why?
|
Hospital Costs | 1 | 2002 | 959 | 0.030 |
Why?
|
Hemodynamics | 4 | 1997 | 4199 | 0.030 |
Why?
|
Lactones | 1 | 2018 | 316 | 0.030 |
Why?
|
Myocardial Stunning | 1 | 1995 | 67 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 280 | 0.030 |
Why?
|
Calibration | 1 | 2018 | 822 | 0.030 |
Why?
|
Dextropropoxyphene | 2 | 1966 | 26 | 0.030 |
Why?
|
Drug Interactions | 1 | 2000 | 1418 | 0.030 |
Why?
|
Sweden | 1 | 2018 | 1382 | 0.030 |
Why?
|
Myxoma | 2 | 1987 | 114 | 0.030 |
Why?
|
Patient Discharge | 1 | 2008 | 3491 | 0.030 |
Why?
|
Subcutaneous Tissue | 1 | 2015 | 131 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2009 | 4265 | 0.030 |
Why?
|
Forecasting | 1 | 2003 | 2945 | 0.030 |
Why?
|
Respiration | 2 | 1989 | 1668 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2004 | 1568 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1376 | 0.030 |
Why?
|
Population Surveillance | 1 | 2024 | 2597 | 0.030 |
Why?
|
Sex Distribution | 2 | 2009 | 2280 | 0.030 |
Why?
|
Age Distribution | 1 | 1999 | 2875 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2649 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 6346 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1191 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 1996 | 544 | 0.030 |
Why?
|
Diuretics | 1 | 1996 | 614 | 0.030 |
Why?
|
Research | 1 | 2001 | 1981 | 0.030 |
Why?
|
Heparin | 2 | 2008 | 1636 | 0.030 |
Why?
|
Body Mass Index | 5 | 2010 | 13055 | 0.030 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2012 | 67 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2018 | 812 | 0.030 |
Why?
|
Oxytocin | 2 | 1967 | 403 | 0.020 |
Why?
|
Drug Packaging | 1 | 1972 | 44 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2012 | 222 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2002 | 2734 | 0.020 |
Why?
|
Electric Countershock | 1 | 2015 | 534 | 0.020 |
Why?
|
Anesthesia, Obstetrical | 2 | 1965 | 235 | 0.020 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2015 | 291 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2012 | 163 | 0.020 |
Why?
|
Obstetric Labor, Premature | 2 | 1970 | 268 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 1991 | 1379 | 0.020 |
Why?
|
Treatment Failure | 2 | 2011 | 2664 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1992 | 642 | 0.020 |
Why?
|
Ethylamines | 1 | 1970 | 17 | 0.020 |
Why?
|
Analgesics | 3 | 1968 | 1071 | 0.020 |
Why?
|
Amino Alcohols | 1 | 1970 | 19 | 0.020 |
Why?
|
Lung Diseases | 1 | 2001 | 1944 | 0.020 |
Why?
|
Sympatholytics | 1 | 1970 | 82 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 2015 | 472 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2015 | 841 | 0.020 |
Why?
|
Nomograms | 1 | 2012 | 236 | 0.020 |
Why?
|
Fetus | 2 | 1968 | 1882 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3301 | 0.020 |
Why?
|
Thrombectomy | 1 | 2015 | 675 | 0.020 |
Why?
|
Electric Power Supplies | 1 | 2010 | 96 | 0.020 |
Why?
|
Intermittent Claudication | 1 | 2012 | 305 | 0.020 |
Why?
|
Scopolamine | 1 | 1990 | 93 | 0.020 |
Why?
|
Catheterization | 1 | 2015 | 1431 | 0.020 |
Why?
|
Cineangiography | 1 | 1989 | 108 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 369 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 200 | 0.020 |
Why?
|
Freeze Drying | 2 | 1967 | 97 | 0.020 |
Why?
|
Antithrombins | 1 | 2011 | 294 | 0.020 |
Why?
|
Nicotinic Acids | 1 | 1968 | 33 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 277 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2942 | 0.020 |
Why?
|
Isosorbide Dinitrate | 1 | 2008 | 34 | 0.020 |
Why?
|
Theophylline | 1 | 1968 | 133 | 0.020 |
Why?
|
Amlodipine | 1 | 2008 | 84 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10868 | 0.020 |
Why?
|
Europe | 1 | 1995 | 3441 | 0.020 |
Why?
|
Metoprolol | 1 | 2008 | 90 | 0.020 |
Why?
|
Vascular Patency | 1 | 1991 | 917 | 0.020 |
Why?
|
Consent Forms | 1 | 2008 | 55 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1886 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2004 | 3447 | 0.020 |
Why?
|
Erysipelothrix | 1 | 1967 | 3 | 0.020 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1798 | 0.020 |
Why?
|
Levallorphan | 1 | 1967 | 1 | 0.020 |
Why?
|
Microbiology | 1 | 1968 | 70 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2011 | 553 | 0.020 |
Why?
|
Meperidine | 1 | 1967 | 37 | 0.020 |
Why?
|
Probability | 1 | 2012 | 2483 | 0.020 |
Why?
|
Dermoid Cyst | 1 | 1967 | 92 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1968 | 0.020 |
Why?
|
Muscles | 2 | 1968 | 1582 | 0.020 |
Why?
|
Hematocrit | 1 | 2008 | 623 | 0.020 |
Why?
|
Abortion, Habitual | 1 | 1967 | 63 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2009 | 643 | 0.020 |
Why?
|
Uterine Diseases | 1 | 1967 | 108 | 0.020 |
Why?
|
Dogs | 3 | 1981 | 3845 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36854 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 594 | 0.020 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1967 | 147 | 0.020 |
Why?
|
Muscle Contraction | 2 | 1968 | 1209 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1629 | 0.020 |
Why?
|
Labor Pain | 1 | 1965 | 15 | 0.020 |
Why?
|
Labor, Induced | 1 | 1967 | 156 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6673 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1967 | 584 | 0.010 |
Why?
|
Clinical Enzyme Tests | 1 | 1984 | 114 | 0.010 |
Why?
|
Posture | 1 | 1989 | 957 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 6236 | 0.010 |
Why?
|
Pregnancy | 13 | 2006 | 30265 | 0.010 |
Why?
|
Obstetric Labor Complications | 1 | 1967 | 244 | 0.010 |
Why?
|
Heart Septum | 1 | 1985 | 304 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1586 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3421 | 0.010 |
Why?
|
Mycoplasma pneumoniae | 1 | 1983 | 43 | 0.010 |
Why?
|
Obesity | 1 | 2006 | 13091 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1757 | 0.010 |
Why?
|
Parasympatholytics | 1 | 1963 | 89 | 0.010 |
Why?
|
Pharmacology | 1 | 1963 | 97 | 0.010 |
Why?
|
Pneumonia, Mycoplasma | 1 | 1983 | 50 | 0.010 |
Why?
|
Heart Atria | 2 | 1987 | 1361 | 0.010 |
Why?
|
Flucytosine | 1 | 1983 | 33 | 0.010 |
Why?
|
Oxytocics | 1 | 1963 | 67 | 0.010 |
Why?
|
Anesthesia | 2 | 1965 | 1596 | 0.010 |
Why?
|
Amiodarone | 1 | 2004 | 217 | 0.010 |
Why?
|
Muscle Relaxants, Central | 1 | 1963 | 93 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26395 | 0.010 |
Why?
|
Amphotericin B | 1 | 1983 | 143 | 0.010 |
Why?
|
Pain | 2 | 1968 | 5100 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1328 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1987 | 619 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2006 | 497 | 0.010 |
Why?
|
Dietary Fats | 1 | 2010 | 2002 | 0.010 |
Why?
|
Angiography | 1 | 1987 | 1598 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.010 |
Why?
|
Primary Prevention | 1 | 2009 | 1187 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 4940 | 0.010 |
Why?
|
Complement C4 | 1 | 1982 | 216 | 0.010 |
Why?
|
Arteries | 1 | 1967 | 1126 | 0.010 |
Why?
|
Women's Health | 1 | 2011 | 2081 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 13048 | 0.010 |
Why?
|
Heart Block | 1 | 1983 | 390 | 0.010 |
Why?
|
Motor Activity | 1 | 2011 | 2713 | 0.010 |
Why?
|
Early Ambulation | 1 | 2001 | 49 | 0.010 |
Why?
|
Documentation | 1 | 1968 | 917 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22379 | 0.010 |
Why?
|
Societies, Medical | 1 | 1992 | 3968 | 0.010 |
Why?
|
Complement C3 | 1 | 1982 | 434 | 0.010 |
Why?
|
Equipment Safety | 1 | 2001 | 250 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3859 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3112 | 0.010 |
Why?
|
Mortality | 1 | 2010 | 2914 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2001 | 848 | 0.010 |
Why?
|
Pulse | 2 | 1970 | 218 | 0.010 |
Why?
|
Aneurysm, False | 1 | 2001 | 263 | 0.010 |
Why?
|
Anemia | 1 | 2008 | 1517 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1990 | 2593 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1978 | 305 | 0.010 |
Why?
|
Adolescent | 4 | 2006 | 89244 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2716 | 0.010 |
Why?
|
Cardiac Volume | 1 | 1978 | 197 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14794 | 0.010 |
Why?
|
Obstetrics | 1 | 1963 | 682 | 0.010 |
Why?
|
Hematoma | 1 | 2001 | 768 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1980 | 746 | 0.010 |
Why?
|
Observer Variation | 1 | 2002 | 2623 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4056 | 0.010 |
Why?
|
Emotions | 1 | 1968 | 2768 | 0.010 |
Why?
|
Methods | 2 | 1972 | 1066 | 0.010 |
Why?
|
Physical Endurance | 1 | 1997 | 370 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1967 | 2044 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14752 | 0.010 |
Why?
|
Home Care Services | 1 | 1981 | 660 | 0.010 |
Why?
|
Hormones | 1 | 1997 | 870 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1967 | 2974 | 0.010 |
Why?
|
Aortic Valve | 1 | 1983 | 1969 | 0.010 |
Why?
|
Mice | 1 | 2019 | 82072 | 0.010 |
Why?
|
Germany, East | 1 | 1972 | 6 | 0.010 |
Why?
|
Reoperation | 1 | 1983 | 4342 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1547 | 0.010 |
Why?
|
Electricity | 1 | 1972 | 177 | 0.010 |
Why?
|
Immune Sera | 1 | 1972 | 605 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1978 | 1112 | 0.010 |
Why?
|
Diet | 1 | 2009 | 8088 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1967 | 4064 | 0.010 |
Why?
|
Propanolamines | 1 | 1991 | 164 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2006 | 4530 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1967 | 4919 | 0.010 |
Why?
|
Uterine Rupture | 1 | 1970 | 67 | 0.010 |
Why?
|
Magnetics | 1 | 1972 | 599 | 0.010 |
Why?
|
Spirometry | 1 | 1972 | 929 | 0.000 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1991 | 582 | 0.000 |
Why?
|
Fetal Heart | 1 | 1970 | 281 | 0.000 |
Why?
|
Placebos | 1 | 1993 | 1667 | 0.000 |
Why?
|
Administration, Cutaneous | 1 | 1990 | 716 | 0.000 |
Why?
|
Psychophysiology | 1 | 1968 | 137 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1987 | 372 | 0.000 |
Why?
|
Neurophysiology | 1 | 1968 | 145 | 0.000 |
Why?
|
Injections, Intra-Arterial | 1 | 1967 | 181 | 0.000 |
Why?
|
Epinephrine | 1 | 1970 | 794 | 0.000 |
Why?
|
Respiratory Tract Diseases | 1 | 1972 | 744 | 0.000 |
Why?
|
Bacteriology | 1 | 1946 | 8 | 0.000 |
Why?
|
Genital Neoplasms, Female | 1 | 1972 | 538 | 0.000 |
Why?
|
Umbilical Arteries | 1 | 1967 | 77 | 0.000 |
Why?
|
Electrocoagulation | 1 | 1967 | 157 | 0.000 |
Why?
|
Oscillometry | 1 | 1967 | 150 | 0.000 |
Why?
|
Phenols | 1 | 1970 | 526 | 0.000 |
Why?
|
Vagina | 1 | 1972 | 849 | 0.000 |
Why?
|
Uterine Inertia | 1 | 1966 | 29 | 0.000 |
Why?
|
Patients | 1 | 1993 | 908 | 0.000 |
Why?
|
Diazepam | 1 | 1967 | 214 | 0.000 |
Why?
|
Abdomen | 1 | 1972 | 1137 | 0.000 |
Why?
|
Umbilical Cord | 1 | 1967 | 179 | 0.000 |
Why?
|
Water Microbiology | 1 | 1946 | 117 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1967 | 556 | 0.000 |
Why?
|
Fungi | 1 | 1968 | 345 | 0.000 |
Why?
|
Autonomic Nervous System | 1 | 1990 | 709 | 0.000 |
Why?
|
Vaginal Smears | 1 | 1967 | 505 | 0.000 |
Why?
|
Viruses | 1 | 1968 | 373 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1967 | 627 | 0.000 |
Why?
|
Vaccines | 1 | 1972 | 843 | 0.000 |
Why?
|
Prednisone | 1 | 1967 | 1567 | 0.000 |
Why?
|
Progesterone | 1 | 1967 | 752 | 0.000 |
Why?
|
Infertility, Female | 1 | 1967 | 764 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1983 | 1126 | 0.000 |
Why?
|
Water | 1 | 1946 | 1421 | 0.000 |
Why?
|
Delivery, Obstetric | 1 | 1967 | 955 | 0.000 |
Why?
|
Gestational Age | 1 | 1967 | 3621 | 0.000 |
Why?
|
Bacteria | 1 | 1968 | 2216 | 0.000 |
Why?
|
Germany, West | 1 | 1972 | 13 | 0.000 |
Why?
|
Diagnostic Techniques, Surgical | 1 | 1972 | 9 | 0.000 |
Why?
|
Genital Diseases, Female | 1 | 1972 | 192 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1967 | 26428 | 0.000 |
Why?
|